RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

This study tests an experimental RSV vaccine in Chinese adults aged 18 to 59 who have health conditions that put them at higher risk for severe RSV disease. Researchers will check if the vaccine produces a strong immune response in this group compared to older adults (60+) who re…

This study tests a new nasal spray vaccine (BLB-201) for RSV, a common virus that can cause serious breathing problems in young children. About 137 infants and children aged 8 to 59 months will receive either the vaccine or a placebo. The goal is to see if the vaccine is safe and…

This study looks at how well an RSV vaccine works and how safe it is in adults aged 18 and older who have had a lung or kidney transplant. Researchers will check if the immune response from a previous dose lasts and what happens when participants get another dose. The goal is to …

This study tests an experimental antiviral drug, S-337395, in adults with RSV who are not hospitalized but have health conditions that put them at high risk for severe illness. Participants receive either the drug or a placebo within 72 hours of symptoms starting. The main goal i…

This study tests whether the antibiotic azithromycin can help children with severe RSV infection who need breathing support in the ICU. Researchers want to see if it shortens hospital stays and reduces time on oxygen. About 370 children will take part, receiving either azithromyc…

This study looks at 1,000 adults aged 60 and older who are hospitalized in Vietnam with breathing problems or worsening heart/lung conditions. Researchers want to find out how many of these cases are caused by RSV (a common virus) and which types of RSV are involved. The goal is …